New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S2886 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	[First Reprint] SENATE, No. 2886 STATE OF NEW JERSEY 221st LEGISLATURE INTRODUCED MARCH 4, 2024
2		-
3		-	[First Reprint]
	1	+	SENATE, No. 2886 STATE OF NEW JERSEY 221st LEGISLATURE INTRODUCED MARCH 4, 2024
4	2
5	3		SENATE, No. 2886
6	4
7	5		STATE OF NEW JERSEY
8	6
9	7		221st LEGISLATURE
10	8
11	9
12	10
13	11		INTRODUCED MARCH 4, 2024
14	12
15	13
16	14
17		-	Sponsored by: Senator LINDA R. GREENSTEIN District 14 (Mercer and Middlesex~~) Senator SHIRLEY K. TURNER District 15 (Hunterdon and Mercer~~) SYNOPSIS Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs. CURRENT VERSION OF TEXT As ~~reported by the Senate Commerce Committee on February 10, 2025, with amendments~~.
	15	+	Sponsored by: Senator LINDA R. GREENSTEIN District 14 (Mercer and Middlesex) SYNOPSIS Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs. CURRENT VERSION OF TEXT As introduced.
18	16
19	17
20	18
21	19		Sponsored by:
22	20
23	21		Senator LINDA R. GREENSTEIN
24	22
25	23		District 14 (Mercer and Middlesex)
26		-
27		-	Senator SHIRLEY K. TURNER
28		-
29		-	District 15 (Hunterdon and Mercer)
30	24
31	25
32	26
33	27
34	28
35	29
36	30
37	31
38	32
39	33		SYNOPSIS
40	34
41	35		Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.
42	36
43	37
44	38
45	39		CURRENT VERSION OF TEXT
46	40
47		-	As ~~reported by the Senate Commerce Committee on February 10, 2025, with amendments~~.
	41	+	As introduced.
48	42
49	43
50	44
51		-	An Act concerning insulin manufacturer assistance programs and supplementing P.L.2003, c.280 (C.45:14-40 et seq.). Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. a. A pharmacy practice site shall: (1) display ~~1, in a conspicuous manner on the website of the pharmacy,1~~ a notice concerning insulin manufacturer assistance programs, to be created by the Department of 1[Banking and Insurance, at all points of sale~~] Health1~~; and (2) ~~1at the individual's request,1~~ provide a pamphlet concerning insulin manufacturer assistance programs, to be created by the department, to an individual purchasing a prescription for insulin and any individual requesting a pamphlet. b. An insulin manufacturer offering an assistance program may inform the department of its intention to be included in the notices and pamphlets. c. The department shall adopt rules and regulations pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), to effectuate the purposes of this act. 2. This act shall take effect on the first day of the 1[sixth~~] twelfth1~~ month next following the date of enactment, except that the Commissioner of 1[Banking and Insurance~~] Health1~~ may take any anticipatory administrative action in advance as shall be necessary for the implementation of this act.
	45	+	An Act concerning insulin manufacturer assistance programs and supplementing P.L.2003, c.280 (C.45:14-40 et seq.). Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. a. A pharmacy practice site shall: (1) display a notice concerning insulin manufacturer assistance programs, to be created by the Department of Banking and Insurance, at all points of sale; and (2) provide a pamphlet concerning insulin manufacturer assistance programs, to be created by the department, to an individual purchasing a prescription for insulin and any individual requesting a pamphlet. b. An insulin manufacturer offering an assistance program may inform the department of its intention to be included in the notices and pamphlets. c. The department shall adopt rules and regulations pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), to effectuate the purposes of this act. 2. This act shall take effect on the first day of the sixth month next following the date of enactment, except that the Commissioner of Banking and Insurance may take any anticipatory administrative action in advance as shall be necessary for the implementation of this act. STATEMENT This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs. Under this bill, a pharmacy practice site will be required to display a notice, created by the Department of Banking and Insurance, concerning insulin manufacturer assistance programs at all points of sale. A pharmacy practice site will also be required to provide a pamphlet, created by the department, concerning the insulin manufacturer assistance programs to any individual purchasing a prescription for insulin, or to any individual requesting a pamphlet. Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets.
52	46
53	47		An Act concerning insulin manufacturer assistance programs and supplementing P.L.2003, c.280 (C.45:14-40 et seq.).
54	48
55	49
56	50
57	51		Be It Enacted by the Senate and General Assembly of the State of New Jersey:
58	52
59	53
60	54
61	55		1. a. A pharmacy practice site shall:
62	56
63		-	(1) display ~~1, in a conspicuous manner on the website of the pharmacy,1~~ a notice concerning insulin manufacturer assistance programs, to be created by the Department of 1[Banking and Insurance, at all points of sale~~] Health1~~; and
	57	+	(1) display a notice concerning insulin manufacturer assistance programs, to be created by the Department of Banking and Insurance, at all points of sale; and
64	58
65		-	(2) ~~1at the individual's request,1~~ provide a pamphlet concerning insulin manufacturer assistance programs, to be created by the department, to an individual purchasing a prescription for insulin and any individual requesting a pamphlet.
	59	+	(2) provide a pamphlet concerning insulin manufacturer assistance programs, to be created by the department, to an individual purchasing a prescription for insulin and any individual requesting a pamphlet.
66	60
67	61		b. An insulin manufacturer offering an assistance program may inform the department of its intention to be included in the notices and pamphlets.
68	62
69	63		c. The department shall adopt rules and regulations pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), to effectuate the purposes of this act.
70	64
71	65
72	66
73		-	2. This act shall take effect on the first day of the 1[sixth] twelfth1 month next following the date of enactment, except that the Commissioner of 1[Banking and Insurance] Health1 may take any anticipatory administrative action in advance as shall be necessary for the implementation of this act.
	67	+	2. This act shall take effect on the first day of the sixth month next following the date of enactment, except that the Commissioner of Banking and Insurance may take any anticipatory administrative action in advance as shall be necessary for the implementation of this act.
	68	+
	69	+
	70	+
	71	+
	72	+
	73	+	STATEMENT
	74	+
	75	+
	76	+
	77	+	This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.
	78	+
	79	+	Under this bill, a pharmacy practice site will be required to display a notice, created by the Department of Banking and Insurance, concerning insulin manufacturer assistance programs at all points of sale. A pharmacy practice site will also be required to provide a pamphlet, created by the department, concerning the insulin manufacturer assistance programs to any individual purchasing a prescription for insulin, or to any individual requesting a pamphlet. Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets.